|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
Blood, 15 October 2007, Vol. 110, No. 8, pp. 2782.
Phagocytic neutrophils cross-present antigenJOHANNES GUTENBERG-UNIVERSITY MAINZ
In this issue of Blood, Beauvillain and colleagues show that murine as well as human neutrophils are capable of cross-presenting exogenous antigens to CD8+ T cells.
Cross-presentation—the ability of antigen-presenting cells (APCs) to take up, process, and present extracellular antigens within the MHC class I pathway, resulting in the induction of antigen-specific, cytotoxic CD8+ T cells—is a process important for immunity against tumors, viruses, and bacteria that are not taken up by APCs (for a review, see Shen et al 1). Cross-presentation was demonstrated primarily in dendritic cells, which phagocytose apoptotic particles using specialized receptors or by pinocytosis of extracellular proteins.2,3 Other APCs described with limited ability to cross-present are macrophages, B cells, and liver sinusoidal endothelial cells.1
Neutrophils are the most frequently occurring leukocytes in the body (50%-65%). Every day, our bone marrow releases approximately 1011 neutrophils into circulation. Upon local release of proinflammatory mediators (eg, IL-1, TNF Neutrophils are cells with a very short life span. After contact with pathogens, their viability is prolonged, but ultimately, all neutrophils die of programmed cell death within a few hours or days. Prior studies suggested that apoptotic neutrophils containing foreign protein can be phagocytosed by dendritic cells (DCs), leading to cross-presentation of this exogeneous antigen.1 Considering the high number of apoptotic neutrophils with antigen present in inflamed tissue early on, this indirect way of activating adaptive immunity seems reasonable. Beauvillain and colleagues show for the first time that neutrophils can directly cross-prime T cells themselves. They demonstrate that neutrophils can function as antigen-presenting cells: they rapidly cross-present antigen (within a few hours) as potently as macrophages, but not as strongly as dendritic cells. Especially in light of the speed and the large number of neutrophils in inflammation, this process may be highly relevant for T-cell priming in vivo. The present findings raise a number of interesting questions: in vivo, are the numbers of neutrophils carrying antigen and migrating to draining lymph nodes sufficient to induce efficient CD8 priming? What about their short life span as compared with the need to migrate to the lymph node to encounter naive T cells and cross-present? Can neutrophils be utilized as targets to induce protective CD8 responses against tumors? As suggested by the report of Beauvillain and colleagues, cross-priming by neutrophils also occurs in the absence of CD4 help—a finding that will have to be confirmed. These and more interesting questions, including whether this process is relevant for real disease models, will have to be answered in the near future.
Footnotes
Conflict-of-interest disclosure: The author declares no competing financial interests.
REFERENCES
  CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||
) from stromal cells, neutrophils rapidly migrate toward the infected site.